Asieris Pharmaceuticals is a Chinese biotech company.
Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 11, 2020 | Series D | ¥700M | 3 | — | — | Detail |
Jun 28, 2020 | Series C | ¥290M | 1 | — | — | Detail |
Dec 29, 2017 | Series B | ¥100M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Haoshuo Zhier Fund | — | Series D |
IFSC | — | Series D |
Homsun Capital | — | Series D |
Huayin Finance & Investment | — | Series C |
Phoenix Fund | — | Series B |